<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE 13D
UNDER SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 5 )
Food Technology Service, Inc.
(formerly Vindicator, Inc.)
-------------------------------------
(Name of Issuer)
Common Shares, $0.01 Par Value
-------------------------------------
(Title of Class of Securities)
927341107
-------------------------------------
(CUSIP Number)
David L. Nicholds, Esq.
MDS Nordion Inc.
447 March Road
Kanata, Ontario, Canada K2K 1X8
-------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
Letter Agreement signed April 28, 2000, effective as of February 4, 2000
----------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement
If the filing person has previously filed a statement on Schedule 13D to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box. [ ]
Check the following box if a fee is being paid with the statement [ ]. (A fee
is not required only if the reporting person: (1) has a pervious statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
<PAGE> 2
The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purposes of Section 13 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 3
SCHEDULE 13D
- -------------------------------- -----------------------------
CUSIP NO. 927341107 PAGE 1 OF 6 PAGES
---------------------- ------- -------
- -------------------------------- -----------------------------
- ----------------- -------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION OF ABOVE PERSON.
MDS Nordion Inc. (formerly Nordion International Inc.)
- ----------------- -------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*. (a) [ ]
(b) [X]
- ----------------- -------------------------------------------------------------
3 SEC USE ONLY
- ----------------- -------------------------------------------------------------
4 SOURCE OF FUNDS* N/A
- ----------------- -------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e). [ ]
- ----------------- -------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION.
Ontario, Canada
- ----------------- ---------- --------------------------------------------------
Number of 7 SOLE VOTING POWER:
Shares
Beneficially
Owned by
each
Reporting
Person with
- ----------------- ---------- --------------------------------------------------
8 SHARED VOTING POWER: 6,232,992
- ----------------- ---------- --------------------------------------------------
9 SOLE DISPOSITIVE POWER:
- ----------------- ---------- --------------------------------------------------
10 SHARED DISPOSITIVE POWER: 6,232,992
- ----------------- -------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
6,232,992
- ----------------- -------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
- ----------------- -------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 56.1%
---------
- ----------------- -------------------------------------------------------------
14 TYPE OF REPORTING PERSON* CO
- ----------------- -------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 4
SCHEDULE 13D
- -------------------------------- -----------------------------
CUSIP NO. 927341107 PAGE 2 OF 6 PAGES
---------------------- ------- -------
- -------------------------------- -----------------------------
- ----------------- -------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION OF ABOVE PERSON.
Laboratoires MDS Quebec Ltee
- ----------------- -------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*. (a) [ ]
(b) [X]
- ----------------- -------------------------------------------------------------
3 SEC USE ONLY
- ----------------- -------------------------------------------------------------
4 SOURCE OF FUNDS* N/A
- ----------------- -------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e). [ ]
- ----------------- -------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION.
Quebec, Canada
- ----------------- ---------- --------------------------------------------------
Number of 7 SOLE VOTING POWER:
Shares
Beneficially
Owned by
each
Reporting
Person with
- ----------------- ---------- --------------------------------------------------
8 SHARED VOTING POWER: 6,232,992
- ----------------- ---------- --------------------------------------------------
9 SOLE DISPOSITIVE POWER:
- ----------------- ---------- --------------------------------------------------
10 SHARED DISPOSITIVE POWER: 6,232,992
- ----------------- -------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
6,232,992
- ----------------- -------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
- ----------------- -------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 56.1%
----------
- ----------------- -------------------------------------------------------------
14 TYPE OF REPORTING PERSON* CO
- ----------------- -------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 5
SCHEDULE 13D
- -------------------------------- -----------------------------
CUSIP NO. 927341107 PAGE 3 OF 6 PAGES
---------------------- ------- -------
- -------------------------------- -----------------------------
- ----------------- -------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION OF ABOVE PERSON.
MDS INC.
- ----------------- -------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*. (a) [ ]
(b) [X]
- ----------------- -------------------------------------------------------------
3 SEC USE ONLY
- ----------------- -------------------------------------------------------------
4 SOURCE OF FUNDS* N/A
- ----------------- -------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e). [ ]
- ----------------- -------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION.
Ontario, Canada
- ----------------- ---------- --------------------------------------------------
Number of 7 SOLE VOTING POWER:
Shares
Beneficially
Owned by
each
Reporting
Person with
- ----------------- ---------- --------------------------------------------------
8 SHARED VOTING POWER: 6,232,992
- ----------------- ---------- --------------------------------------------------
9 SOLE DISPOSITIVE POWER:
- ----------------- ---------- --------------------------------------------------
10 SHARED DISPOSITIVE POWER: 6,232,992
- ----------------- -------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
6,232,992
- ----------------- -------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
- ----------------- -------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 56.1%
----------
- ----------------- -------------------------------------------------------------
14 TYPE OF REPORTING PERSON* CO
- ----------------- -------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 6
Item 1. SECURITY AND ISSUER.
Shares of Common Stock, $0.01 par value
Food Technology Service, Inc.
502 Prairie Mine Road
Mulberry, Florida 33860 USA
Item 2. IDENTITY AND BACKGROUND
N/A
Item 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
N/A
Item 4. PURPOSE OF TRANSACTION
The purpose of the transaction is to provide that MDS Nordion Inc.
("Nordion"), effective February 4, 2000, waive its right to convert
interest accruing on the outstanding debt of Food Technology Service,
Inc. ("FTSI") into shares of FTSI, until January 1, 2001. FTSI and
Nordion have agreed that interest payable on FTSI's outstanding
indebtedness to Nordion, effective as of February 4, 2000 accrue to
Nordion on a calendar quarter basis at the rate of Nation's Bank prime
rate in effect on the 1st day of each quarter, plus 1% and payable on
the last day of each quarter.
Item 5. INTEREST IN SECURITIES OF THE ISSUER
N/A
Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDING OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER.
See item 4.
Item 7. MATERIALS TO BE FILED AS EXHIBITS
Letter Agreement dated April 28, 2000.
<PAGE> 7
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief
the undersigned certify that the information set forth in this statement is
true and correct.
Dated: April 28, 2000
MDS NORDION INC.,
By: /s/ David L. Nicholds
-------------------------------------
Name: David L. Nicholds
Title: Vice President, General Counsel
MDS INC.,
By: /s/ Peter E. Brent
-------------------------------------
Name: Peter E. Brent
Title: Senior Vice President & General
Counsel
LABORATORIES MDS QUEBEC LTEE.
By: /s/ Peter E. Brent
-------------------------------------
Name: Peter E. Brent
Title: Senior Vice President & General
Counsel
